Analyst Price Targets — CHE
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| January 22, 2026 6:03 am | Brian Tanquilut | Jefferies | $475.00 | $453.53 | StreetInsider | Jefferies Downgrades Chemed (CHE) to Hold |
| September 2, 2025 8:57 am | — | Jefferies | $550.00 | $464.00 | TheFly | Chemed upgraded to Buy from Hold at Jefferies |
| November 5, 2024 11:58 am | Frank Morgan | RBC Capital | $633.00 | $534.41 | StreetInsider | Chemed (CHE) PT Lowered to $633 at RBC Capital |
| May 21, 2024 6:11 am | Frank Morgan | RBC Capital | $697.00 | $564.34 | StreetInsider | Chemed (CHE) PT Lowered to $697 at RBC Capital |
| April 28, 2022 9:16 am | — | RBC Capital | $592.00 | $492.25 | Benzinga | RBC Capital Maintains Outperform on Chemed, Raises Price Target to $592 |
Latest News for CHE
Bank of New York Mellon Corp acquired a new position in shares of Chemed Corporation (NYSE: CHE) in the undefined quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 94,045 shares of the company's stock, valued at approximately $43,800,000. Bank of New York Mellon Corp owned approximately
Chemed (CHE) reported earnings 30 days ago. What's next for the stock?
Investors looking for stocks in the Medical - Outpatient and Home Healthcare sector might want to consider either Option Care (OPCH) or Chemed (CHE). But which of these two stocks presents investors with the better value opportunity right now?
Deutsche Bank AG acquired a new position in shares of Chemed Corporation (NYSE: CHE) during the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 16,747 shares of the company's stock, valued at approximately $7,800,000. Deutsche Bank AG owned about 0.13% of Chemed
NEW YORK--(BUSINESS WIRE)---- $CHE #NYSE--Scott+Scott Attorneys at Law LLP has launched an urgent investigation into whether certain officers and directors of Chemed Corporation (NYSE: CHE) failed to manage Chemed in an acceptable manner, breaching their fiduciary duties to Chemed, and whether Chemed and its shareholders have suffered damages as a result. Attorney Joseph A. Pettigrew is heading the…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.